Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
$NVO
Novo Nordisk has been on a downtrend and fighting for survival. Last lifeline is the $33.66/share region. I will not be buying this, as I could easily lose 50% of my holding if we lose the 2021 yearly low of $33.6/share.
A lot of disgusting things are going on in this company, from litigation issues with their competitor to a smear campaign on the competitor's products.
Bulls must defend the $33.66/share, and one interesting news item that came out on Friday is that Nordisk and Hims&Hers have come into agreement on selling the weight loss drugs. $NVO plans to sell its weight loss drugs on Hims&Hers Health's platform
Let's see if that will bazooka $NVO to the SUPPLY zone $47.23-$51.59 per share
#NFA #SENKOREQUESTSESSION